The effect of folate status on the uptake of physiologically relevant compounds by Caco-2 cells

European Journal of Pharmacology

Volumn 640, Issue 1-3, 2010, Pages 29-37

  Tavares, Sandra ^a   Sousa, Joana ^a   Gonçalves, Pedro ^a   Araújo, João R ^a   Martel, Fátima ^a  

^a University of Porto   (Portugal)

Author keywords

Bioactive compound; Caco 2 cell; Folate deficiency; Membrane transport

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 3 METHYLGLUCOSE; BUTYRIC ACID; CARBON 14; FOLATE RECEPTOR; FOLIC ACID; GLUCOSAMINE; GLUCOSE TRANSPORTER 2; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; MONOCARBOXYLATE TRANSPORTER 1; ORGANIC CATION TRANSPORTER 1; ORGANIC CATION TRANSPORTER 2; ORGANIC CATION TRANSPORTER 3; REDUCED FOLATE CARRIER; SEROTONIN; SODIUM GLUCOSE COTRANSPORTER 2; TRITIUM; BUTYRIC ACID DERIVATIVE; GLUCOSE;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CELL STRAIN CACO 2; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; GROWTH RATE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PRIORITY JOURNAL; STEADY STATE; UPREGULATION; CACO 2 CELL LINE; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; FOLIC ACID DEFICIENCY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSPORT AT THE CELLULAR LEVEL;

1-METHYL-4-PHENYLPYRIDINIUM; APOPTOSIS; BIOLOGICAL TRANSPORT; BUTYRATES; CACO-2 CELLS; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FOLIC ACID; FOLIC ACID DEFICIENCY; GENE EXPRESSION REGULATION; GLUCOSE; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEROTONIN;

EID: 77953811220     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.04.056     Document Type: Article

References (68)

1. Ashokkumar B., Mohammed Z.M., Vaziri N.D., Said H.M. Effect of folate oversupplementation on folate uptake by human intestinal and renal epithelial cells. Am. J. Clin. Nutr. 2007, 86:159-166.
2. Backus H.H., Pinedo H.M., Wouters D., Padron J.M., Molders N., van Der Wilt C.L., van Groeningen C.J., Jansen G., Peters G.J. Folate depletion increases sensitivity of solid tumor cell lines to 5-fluorouracil and antifolates. Int. J. Cancer 2000, 87:771-778.
3. Bailey L.B., Rampersaud G.C., Kauwell G.P.A. Folic acid supplements and fortification affect the risk for neural tube defects, vascular disease and cancer: evolving science. J. Nutr. 2003, 133:1961-1968.
4. Balamurugan K., Said H.M. Role of reduced folate carrier in intestinal folate uptake. Am. J. Physiol. Cell Physiol. 2006, 291:C189-C193.
5. Bissonnette P., Gagné H., Coady M.J., Benabdallah K., Lapointe J.Y., Berteloot A. Kinetic separation and characterization of three sugar transport modes in Caco-2 cells. Am. J. Physiol. 1996, 270:G833-G843.
6. Bradford M.M. A rapid method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
7. Butterworth C.E., Bendich A. Folic acid and the prevention of birth defects. Annu. Rev. Nutr. 1996, 16:73-97.
8. Ciarimboli G. Organic cation transporters. Xenobiotica 2008, 38:936-971.
9. Crott J.W., Liu Z., Keyes M.K., Choi S.W., Jang H., Moyer M.P., Mason J.B. Moderate folate depletion modulates the expression of selected genes involved in cell cycle, intracellular signaling and folate uptake in human colonic epithelial cell lines. J. Nutr. Biochem. 2008, 19:328-335.
10. Cuff M., Dyer J., Jones M., Shirazi-Beechey S.P. The human colonic monocarboxylate transporter isoform 1: its potential importance to colonic tissue homeostasis. Gastroenterology 2005, 128:676-686.
11. Daly K., Cuff M.A., Fung F., Shirazi-Beechey S.P. The importance of colonic butyrate transport to the regulation of genes associated with colonic tissue homeostasis. Biochem. Soc. Trans. 2005, 33:733-735.
12. Delie F., Rubas W. A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model. Crit. Rev. Ther. Drug Carrier Syst. 1997, 14:221-286.
13. Drozdowski L.A., Thompson A.B.R. Intestinal sugar transport. World J. Gastroenterol. 2006, 21:1657-1670.
14. Enerson B.E., Drewes L.R. Molecular features, regulation, and function of monocarboxylate transporters: implications for drug delivery. J. Pharm. Sci. 2003, 92:1531-1544.
15. 2 receptors on longitudinal muscle of guinea pig ileum. J. Recept. Res. 1984, 4:113-126.
16. Erspamer V. Occurrence of indolealkylamines in nature. Handbook of Experimental Pharmacology: 5-Hydroxytryptamine and Related Indolealkylamines 1966, 132-181. Springer-Verlag, New York. V. Erspamer (Ed.).
17. Ganapathy V., Gopal E., Miyauchi S., Prasad P.D. Biological functions of SLC5A8, a candidate tumour suppressor. Biochem. Soc. Trans. 2005, 33:237-240.
18. Gates S.B., Mendelsohn L.G., Shackelford K.A., Habeck L.L., Kursar J.D., Gossett L.S., Worzalla J.F., Shih C., Grindey G.B. Characterization of folate receptor from normal and neoplastic murine tissue: influence of dietary folate on folate receptor expression. Clin. Cancer Res. 1996, 2:1135-1141.
19. Gershon M.D. Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel. Aliment. Pharmacol. Ther. 1999, 13(Suppl. 2):15-30.
20. Gershon M.D., Robinson R., Ross L.L. Functional anatomy of the enteric nervous system. Physiology of the Gastrointestinal Tract 1994, 381-422. Raven Press, New York. 3rd Edn. L.R. Johnson, D.H. Alpers, E.D. Jacobson, E.H. Walsh (Eds.).
21. Gonçalves P., Araújo J.R., Azevedo I., Martel F. Lack of significant effect of cannabinoids upon the uptake of 2-deoxy-d-glucose by Caco-2 cells. Pharmacology 2008, 82:30-37.
22. Gonçalves P., Araújo J.R., Pinho M.J., Martel F. Modulation of butyrate transport in Caco-2 cells. Naunyn-Schmiedeber'g Arch. Pharmacol. 2009, 379:325-336.
23. Gonçalves, P., Araújo, J.R., Martel F., (in press). Effect of some natural mineral waters in nutrient uptake by Caco-2 cells. Int. J. Vitam. Nutr.
24. Gründemann D., Liebich G., Kiefer N., Köster S., Schömig E. Selective substrates for non-neuronal monoamine transporters. Mol. Pharmacol. 1999, 56:1-10.
25. Gupta N., Martin P.M., Prasad P.D., Ganapathy V. SLC5A8 (SMCT1)-mediated transport of butyrate forms the basis for the tumor suppressive function of the transporter. Life Sci. 2006, 78:2419-2425.
26. Hadjiagapiou C., Schmidt L., Dudeja P.K., Layden T.J., Ramaswamy K. Mechanism(s) of butyrate transport in caco-2 cells: role of monocarboxylate transporter 1. Am. J. Physiol. Gastrointest. Liver Physiol. 2000, 279:G775-G780.
27. Halestrap A.P., Meredith D. The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Arch. - Eur J. Physiol. 2004, 447:619-628.
28. Hayashi I., Sohn K.-J., Stempak J.M., Croxford R., Kim Y.-I. Folate deficiency induces cell-specific changes in the steady-state transcript levels of genes involved in folate metabolism and 1-carbon transfer reactions in human colonic epithelial cells. J. Nutr. 2007, 137:607-613.
29. Herbert V. Folic acid. Modern Nutrition in Health and Disease 1999, 433-446. Lippincott, Williams & Wilkins, London. 9th Edn. M.E. Shils, J.A. Olson, M. Shike, A.H. Ross (Eds.).
30. Ifergan I., Assaraf Y.G. Molecular mechanisms of adaptation to folate deficiency. Vitam. Horm. 2008, 79:99-143.
31. Ifergan I., Jansen G., Assaraf Y.G. The reduced folate carrier (RFC) is cytotoxic to cells under conditions of severe folate deprivation. RFC as a double edged sword in folate homeostasis. J. Biol. Chem. 2008, 283:20,687-20,695.
32. Imada-Shirakata Y., Kotera T., Ueda S., Okuma M. Serotonin activates electrolyte transport via 5HT2A receptor in colonic crypt cells. Biochem. Biophys. Res. Commun. 1997, 230:437-441.
33. + in mouse brain. Neurosci. Lett. 1989, 101:83-88.
34. Hubner R.A., Houlston R.S. Folate and colorectal cancer prevention. Br. J. Cancer 2009, 100:233-239.
35. Kamen B. Folate and antifolate pharmacology. Semin. Oncol. 1997, 24:S18-S30.
36. Kellett G.L., Brot-Laroche E. Apical GLUT2: a major pathway of intestinal sugar absorption. Diabetes 2005, 54:3056-3062.
37. Kim Y.I. Role of folate in colon cancer development and progression. J. Nutr. 2003, 133:3731S-3739S.
38. Kim M.K., Shim C.-K. The transport of organic cations in the small intestine: current knowledge and emerging concepts. Arch. Pharm. Res. 2006, 29:605-616.
39. Koepsell H., Endou H. The SLC22 drug transporter family. Pflugers Arch. - Eur. J. Physiol. 2004, 447:666-676.
40. Lacey S.W., Sanders J.M., Rothberg K.G., Anderson R.G., Kamen B.A. Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol. J. Clin. Invest. 1989, 84:715-720.
41. Lambert D.W., Wood I.S., Ellis A., Shirazi-Beechey S.P. Molecular changes in the expression of human colonic nutrient transporters during the transition from normality to malignancy. Br. J. Cancer 2002, 86:1262-1269.
42. Lemos C., Kathmann I., Giovannetti E., Beliën J.A., Scheffer G.L., Calhau C., Jansen G., Peters G.J. Cellular folate status modulates the expression of BCRP and MRP multidrug transporters in cancer cell lines from different origins. Mol. Cancer Ther. 2009, 8:655-664.
43. Lemos C., Kathmann I., Giovannetti E., Calhau C., Jansen G., Peters G.J. Impact of cellular folate status and epidermal growth factor receptor expression on BCRP/ABCG2-mediated resistance to gefitinib and erlotinib. Br. J. Cancer 2009, 100:1120-1127.
44. Liu M., Ge Y., Cabelof D.C., Aboukameel A., Heydari A.R., Mohammad R., Matherly L.H. Structure and regulation of the murine reduced folate carrier gene: identification of four noncoding exons and promoters and regulation by dietary folates. J. Biol. Chem. 2005, 280:5588-5597.
45. Lucock M. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol. Genet. Metab. 2000, 71:121-138.
46. + in human intestinal epithelial (Caco-2) cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 2000, 361:505-513.
47. Martel F., Gründemann D., Calhau C., Schömig E. Apical uptake of organic cations by human intestinal Caco-2 cells: putative involvement of ASF transporters. Naunyn-Schmiedeberg's Arch. Pharmacol. 2001, 363:40-49.
48. Martel F., Monteiro R., Lemos C. Uptake of serotonin at the apical and basolateral membrane of human intestinal epithelial (Caco-2) cells occurs through the neuronal serotonin transporter (SERT). J. Pharmacol. Exp. Ther. 2003, 306:355-362.
49. Martel F., Gonçalves P., Azevedo I. Absorption of folate by Caco-2 cells is not affected by high glucose concentration. Eur. J. Pharmacol. 2006, 551:19-26.
50. Matherly L.H., Goldman I.D. Membrane transport of folates. Vitam. Horm. 2003, 66:403-456.
51. Morris M.E., Felmlee M.A. Overview of the proton-coupled MCT (SLC16A) family of transporters: characterization, function and role in the transport of the drug of abuse gamma-hydroxybutyric acid. AAPS J. 2008, 10:311-321.
52. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
53. Myzuka A., Tarkany O., Yelizanof V., et al. Non-linear Regression (curve fit). GraphPad Prism for Windows. San Diego, CA., USA 2005.
54. Novakovic P., Stempak J.M., Sohn K.J., Kim Y.I. Effects of folate deficiency on gene expression in the apoptosis and cancer pathways in colon cancer cells. Carcinogenesis 2006, 27:916-924.
55. Qiu A., Jansen M., Sakaris A., Min S.H., Chattopadhyay S., Tsai E., Sandoval C., Zhao R., Akabas M.H., Goldman I.D. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell 2006, 127:917-928.
56. Qiu A., Min S.H., Jansen M., Malhotra U., Tsai E., Cabelof D.C., Matherly L.H., Zhao R., Akabas M.H., Goldman I.D. Rodent intestinal folate transporters (SLC46A1): secondary structure, functional properties, and response to dietary folate restriction. Am. J. Physiol. Cell Physiol. 2007, 293:C1669-C1678.
57. Said H.M. Recent advances in carrier-mediated intestinal absorption of water-soluble vitamins. Annu. Rev. Physiol. 2004, 66:419-446.
58. Said H.M., Chatterjee N., Haq R.U., Subramanian V.S., Ortiz A., Matherly L.H., Sirotnak F.M., Halsted C., Rubin S.A. Adaptive regulation of intestinal folate uptake: effect of dietary folate deficiency. Am. J. Physiol. Cell Physiol. 2000, 279:C1889-C1895.
59. Sayre L.M. Biochemical mechanism of action of the dopaminergic neurotoxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP). Toxicol. Lett. 1989, 48:121-149.
60. 12 in neuropsychiatric diseases: review and treatment recommendations. Expert Rev. Neurother. 2009, 9:1393-1412.
61. Stempak J.M., Sohn K.J., Chiang E.P., Shane B., Kim Y.I. Cell and stage of transformation-specific effects of folate deficiency on methionine cycle intermediates and DNA methylation in an in vitro model. Carcinogenesis 2005, 26:981-990.
62. 12 in health and disease. Nutr. Rev. 2004, 62:S3-S12.
63. Stumpel F., Burcelin R., Jungermann K., Thorens B. Normal kinetics of intestinal glucose absorption in the absence of GLUT2: evidence for a transport pathway requiring glucose phosphorylation and transfer into the endoplasmic reticulum. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:11,330-11,335.
64. Subramanian V.S., Chatterjee N., Said H.M. Folate uptake in the human intestine: promoter activity and effect of folate deficiency. J. Cell. Physiol. 2003, 196:403-408.
65. Wade P.R., Tamir H., Kirchgessner A.L., Gershon M.D. Analysis of the role of 5-HT in the enteric nervous system using anti-idiotypic antibodies to 5-HT receptors. Am. J. Physiol. Gastrointest. Liver Physiol. 1994, 266:G403-G416.
66. Weitman S.D., Lark R.H., Coney L.R., Fort D.W., Frasca V., Zurawski V.R., Kamen B.A. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res. 1992, 52:3396-3401.
67. Wright E.M., Martin M.G., Turk E. Intestinal absorption in health and disease-sugars. Best Pract. Res. Clin. Gastroenterol. 2003, 17:943-956.
68. Zhao R., Matherly L.H., Goldman I.D. Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues. Exp. Rev. Mol. Med. 2009, 11:e4.